"Cyclodextrin reprogrammed the cells in plaques, leading to increased transport of the dissolved cholesterol away from the plaques..."
nature.com : Molecule melts away cholesterol.
"Cyclodextrin dissolves cholesterol crystals and reduces atherosclerotic plaques..."
sciencedaily.com : Drug used for rare disease may be able to treat heart disease.
"Soaked up cholesterol and removed it..."
sciencedaily.com : New hope for treating atheriosclerosis
"have the potential in lowering deaths caused by atherosclerosis..."
ntnu.co : Can a sugar treat atherosclerosis?
"can actually solubilize cholesterol and dissolve the plaques..."
huffpost.com : Cholesterol sweet spot.
A study on the effects of HP-B-CD in transgenic mice with Alzheimer disease showed a dramatic reduction in symptoms and significantly improved spatial learning and memory deficits in mice.
The study concluded HP-B-CD could be a novel therapeutic strategy for Alzheimer disease.
"Diabetic kidney disease"
HP-B-CD has shown promising pre-clinical results in kidney disease. Progression of kidney disease was prevented in mouse models and diabetic kidney disease was prevented or partially prevented in two pre-clinical studies.
"Non-alcoholic fatty liver disease"
Several studies have shown that HP-B-CD reduces liver cholesterol and cholesterol crystals. HP-B-CD has a substantial effect on cholesterol distribution and cholesterol transporters.
Lipofuscin accumulation in the retinal pigment epithelium is a hallmark of aging. A study was done on the effects of cyclodextrin and found that the beta-cyclodextrin can bind retinal lipofuscin, prevent its oxidation and remove it.
Cholrem patients have also reported improved vision after treatments of CAVADEX®.